AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionIHT Wealth Management, LLC
Latest Disclosed Ownership73,546 shares
Latest Disclosed Value $ 15,995,568
IHT Wealth Management, LLC reports 22.57% increase in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - IHT Wealth Management, LLC filed a 13F-HR form disclosing ownership of 73,546 shares of AbbVie Inc. (US:ABBV) valued at $15,995,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 60,004 shares of AbbVie Inc.. This represents a change in shares of 22.57% during the quarter. The current value of the position is $16,541,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Abbvie COM 00287Y109 73,546 13,542 22.57 15,996 16.67 0.3700
2026-02-17 2025-12-31 13F Abbvie COM 00287Y109 60,004 -752 -1.24 13,710 -2.54 0.3331
2025-11-14 2025-09-30 13F Abbvie COM 00287Y109 60,756 719 1.20 14,067 26.23 0.3558
2025-08-14 2025-06-30 13F Abbvie COM 00287Y109 60,037 -1,971 -3.18 11,144 -14.22 0.3064
2025-05-15 2025-03-31 13F Abbvie COM 00287Y109 62,008 -778 -1.24 12,992 16.44 0.4057
2025-02-14 2024-12-31 13F Abbvie COM 00287Y109 62,786 -9,922 -13.65 11,157 -22.26 0.3600
2024-11-14 2024-09-30 13F Abbvie COM 00287Y109 72,708 15,284 26.62 14,351 45.71 0.4072
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 57,424 -765 -1.31 9,850 -7.05 0.3674
2024-05-15 2024-03-31 13F Abbvie COM 00287Y109 58,189 1,282 2.25 10,596 20.16 0.4248
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 56,907 4,315 8.20 8,819 12.49 0.3932
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 52,592 2,129 4.22 7,839 15.31 0.3975
2023-08-15 2023-06-30 13F ABBVIE COM 00287Y109 50,463 227 0.45 6,799 -15.09 0.3541
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 50,236 248 0.50 8,006 -0.89 0.4570
2023-02-15 2022-12-31 13F ABBVIE COM 00287Y109 49,988 -451 -0.89 8,079 19.34 0.5075
2022-11-22 2022-09-30 13F ABBVIE COM 00287Y109 50,439 7,293 16.90 6,769 2.44 0.5144
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 43,146 -523 -1.20 6,608 -6.65 0.5825
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 43,669 1,190 2.80 7,079 23.07 0.5366
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 42,479 511 1.22 5,752 27.06 0.4241
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 41,968 -290,998 -87.40 4,527 -87.93 0.3685
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 332,966 -2,687 -0.80 37,505 3.25 2.3786
2021-05-18 2021-03-31 13F ABBVIE COM 00287Y109 335,653 37,063 12.41 36,324 13.53 2.6126
2021-02-17 2020-12-31 13F ABBVIE COM 00287Y109 298,590 -26,426 -8.13 31,994 12.39 2.6595
2020-11-19 2020-09-30 13F ABBVIE COM 00287Y109 325,016 279,034 606.83 28,468 530.52 2.8571
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 45,982 -267,341 -85.32 4,515 -81.09 0.6186
2020-05-13 2020-03-31 13F ABBVIE COM 00287Y109 313,323 57,066 22.27 23,872 5.21 3.4370
2020-02-18 2019-12-31 13F ABBVIE COM 00287Y109 256,257 -1,898 -0.74 22,689 16.04 2.6865
2019-11-15 2019-09-30 13F ABBVIE COM 00287Y109 258,155 46,849 22.17 19,553 27.28 2.6587
2019-08-12 2019-06-30 13F ABBVIE COM 00287Y109 211,306 26,613 14.41 15,362 3.21 2.2306
2019-05-16 2019-03-31 13F ABBVIE COM 00287Y109 184,693 48,867 35.98 14,884 18.86 2.4798
2019-02-14 2018-12-31 13F ABBVIE INC COM USD0.00 COM 00287Y109 135,826 109,949 424.89 12,522 411.73 2.4103
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 25,877 2,191 9.25 2,447 11.53 0.5292
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 23,686 3,068 14.88 2,194 16.33 0.5606
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 20,618 -259 -1.24 1,886 -9.20 0.5064
2018-02-14 2017-12-31 13F ABBVIE COM 00287Y109 20,877 5,547 36.18 2,077 49.21 0.5498
2017-11-14 2017-09-30 13F ABBVIE COM 00287Y109 15,330 -1,018 -6.23 1,392 18.57 0.5926
2017-08-14 2017-06-30 13F/A-1 ABBVIE COM 00287Y109 16,348 -343 -2.05 1,174 8.30 0.5686
2017-08-14 2017-06-30 13F ABBVIE COM 00287Y109 16,348 -343 57
2017-05-15 2017-03-31 13F ABBVIE COM 00287Y109 16,691 2,891 20.95 1,084 25.90 0.7227
2017-02-14 2016-12-31 13F ABBVIE COM 00287Y109 13,800 13,800 861 0.6511
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.